Connect your AI

Envoy Medical COCH Change In Fair Value Of Publicly Traded Warrant Liability

Other financials

Income statement

Revenue$39.0K-15.2%

Gross profit-$274.0K-52.2%

Operating income-$6.0M-16.7%

Net income-$4.4M+12.9%

EPS (diluted)-$0.08+72.4%

Balance sheet

Cash & equivalents$25.3M+376%

Total debt$919.0K-2.8%

Total equity$10.2M+142%

Total assets$29.8M+187%

Cash flow

Operating cash flow-$6.1M-62.7%

CapEx$172.0K—

Free cash flow-$5.9M-28.5%

Valuation

Market cap$61M+83.5%

P/S260.7×+111×

Profitability

Gross margin-310.7%+31.6pp

Operating margin-9,881.2%+805pp

Net margin-9,875.6%+771pp

FCF margin-7,626.6%-652pp

Returns & leverage

Return on equity328.7%—

Debt / equity0.1×—

Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept coch:ChangeInFairValueOfPubliclyTradedWarrantLiability.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's change in fair value of publicly traded warrant liability.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Envoy Medical's change in fair value of publicly traded warrant liability?: Envoy Medical (COCH) reported change in fair value of publicly traded warrant liability of $390K in Q1 2026.
How has Envoy Medical's change in fair value of publicly traded warrant liability changed year-over-year?: Envoy Medical's change in fair value of publicly traded warrant liability increased by 301.0% year-over-year, from -$194K to $390K.